Hello, and welcome to the Q1 2023 Revvity Inc. Earnings Conference Call. My name is Alex, and I’ll be coordinating the call today. [Operator Instructions] I will now hand over to your host, Steve Willoughby, SVP of Investor Relations. Please go ahead.

Thank you, operator. Good morning, everyone, and welcome to Revvity’s first quarter 2023 earnings conference call. On the call with me today are Prahlad Singh, our President and Chief Executive Officer; and Max Krakowiak, our Senior Vice President and Chief Financial Officer. Before we begin, I’d like to remind everyone of the Safe Harbor statements that we’ve outlined in our press release issued earlier this morning and also those in our SEC filings. Statements or comments made on this call may be forward-looking statements, which may include but are not necessarily limited to financial projections or other statements of the company’s plans, objectives, expectations or intentions. These matters involve certain risks and uncertainties. The company’s actual results may differ significantly from those projected or suggested by any forward-looking statements due to a variety of factors, which are discussed in detail in our SEC filings. Any forward-looking statements made today represent our views as of today. We disclaim any obligation to update these forward-looking statements in the future, even if our estimates change. So you should not rely on any of today’s forward-looking statements as representing our views as of any date after today. During this call, we will be referring to certain non-GAAP financial measures. A reconciliation of the non-GAAP financial measures we plan to use during this call to the most directly comparable GAAP measures is available as an attachment to our earnings press release. To the extent we use non-GAAP measures during the call that are not reconciled to GAAP, we will provide reconciliations promptly. I’ll now turn it over to our President and Chief Executive Officer, Prahlad Singh. Prahlad?

Thanks Steve, and good morning, everyone. It is great to be speaking to all of you for the first time as Revvity. We are here in Dallas today as we are hosting a global gathering of employees to officially launch the new company and brand this week. Our objective is to not only familiarize and engage our employees with the new brand but also to organize and collaborate in person for the first time as a collective group since before the pandemic. The past few months have been incredibly busy as we have officially closed the latest chapter of our transformation. As you likely saw earlier this week, we launched Revvity as our new brand after receiving shareholder approval to change our company’s name in late April. To change the name and brand identity for a public company with a roughly $3 billion in revenue and over 11,000 employees is a significant undertaking, but one that I am confident in our ability to execute well and I couldn’t be more excited for what the future of Revvity holds. This follows the successful completion of the divestiture of our analytical and enterprise solutions business in mid-March which was also quite the undertaking in and of itself. To give you some quick perspective of the process it entailed, we have to successfully transfer 96 separate facilities, create approximately 40 new legal entities, sign, convey or separate roughly 2,000 different contracts and change the employer for over 5,500 people. Needless to say, it requires substantial effort by many and I am proud that we completed this successfully and on time. At its core, the vision for revenue is founded on the belief that what is believed to be impossible, can instead serve as our inspiration to help customers make new, breakthrough scientific discoveries.…

Thanks Prahlad. Good morning everyone. As Prahlad highlighted, it was a significant and transformational accomplishment to successfully complete the divestiture of our analytical and enterprise solution spaces during the first quarter. This was followed by officially launching the new brand’s Revvity just two days ago. There’s been a tremendous amount of work and effort by so many over the last few years to complete this transformation of the business. But at the same time, it also feels like we are now just getting started and beginning to scratch the surface of our full potential. It is a unique opportunity to name an existing business and I’m excited about how the name Revvity links to our company’s purpose. Rev comes from the concept of revolutionizing, while Vity stems from the Latin word Vita which translates to life. This ability to help our customers revolutionize human life through science is both humbling and energizing experience not only for me personally but for our entire company. As I begin to walk through our financial results, I wanted to remind you that all of my following commentary completely excludes the business that we divested and only includes our life sciences and diagnostic businesses which now make up Revvity. Overall, the business reform well in the first quarter. Our adjusted revenues were $675 million, which was down 30% due to the significant drop in COVID-related revenues compared to a year ago. On a non-COVID basis, our organic growth was 6% which was at the upper end of our expectation despite a slower than expected recovery so far in our China diagnostic business. FX was a 3% headwind which was a point worse than we had expected and we had no contribution from recent acquisitions. As previously mentioned, while we are now excluding all COVID revenue…

Thank you. [Operator Instructions] Our first question for today comes from Patrick Donnelly of Citi. Patrick your line is now open, please go ahead.

Thank you. Our next question comes from Catherine Schulte from Baird. Catherine your line is now open, please go ahead.

Thank you. Our next question comes from Michael Ryskin of Bank of America. Michael, your line is now open, please go ahead.

Thank you. Our next question comes from Jack Meehan of Nephron Research. Jack your line is now open, please go ahead.

Thank you. Our next question comes from Vijay Kumar of Evercore. Vijay your line is now open, please go ahead.

Thank you. Our next question comes from Dan Arias of Stifel. Dan your line is now open, please go ahead.

Thank you. Our next question comes from Josh Waldman of Cleveland. Josh, your line is now open, please go ahead.

Thank you. Our next question comes from Luke Sergott of Barclays. Luke your line is now open, please go ahead.

Thank you. Our next question comes from Matt Sykes of Goldman Sachs. Matt your line is now open, please go ahead.

Thank you. Our next question comes from Dan Brennan of TD Cowen. Dan your line is now open, please go ahead.

Thank you. Our next question comes from Rachel Vatnsdal from JPMorgan. Rachel your line is now open, please go ahead.

Thank you. Our next question comes from Brandon Couillard from Jefferies. Brandon your line is now open, please go ahead.

Thank you. I will now turn the call back over to Steve Willoughby for any further remarks.

Thanks, Alex. Thanks, everyone, for your time today and your questions this morning, and we look forward to speaking with you over the coming weeks and months and, again, next quarter. Have a good day.

Thank you for joining today’s call. You may now disconnect your lines.